Tyrphostin A1
Suppliers
Names
[ CAS No. ]:
2826-26-8
[ Name ]:
Tyrphostin A1
[Synonym ]:
AG 9
(4-Methoxybenzylidene)malonitrile
Tyrphostin A1
Tyrphostin 1
2-(4-Methoxybenzylidene)malononitrile
(4-Methoxybenzylidene)malononitrile
2-[(4-methoxyphenyl)methylidene]malononitrile
2-[(4-methoxyphenyl)methylene]malononitrile
p-methoxybenzylidenemalononitrile
(4-methoxyphenylmethylene)methane-1,1-dicarbonitrile
MFCD00019787
Chemical & Physical Properties
[ Density]:
1.169g/cm3
[ Boiling Point ]:
352.4ºC at 760mmHg
[ Melting Point ]:
113-116ºC(lit.)
[ Molecular Formula ]:
C11H8N2O
[ Molecular Weight ]:
184.19400
[ Flash Point ]:
148.8ºC
[ Exact Mass ]:
184.06400
[ PSA ]:
56.81000
[ LogP ]:
2.12576
[ Vapour Pressure ]:
3.85E-05mmHg at 25°C
[ Index of Refraction ]:
1.589
[ Storage condition ]:
2-8°C
[ Water Solubility ]:
chloroform: soluble50mg/mL, clear, light yellow
MSDS
Safety Information
[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
[ Hazard Codes ]:
Xn
[ Risk Phrases ]:
20/21/22
[ Safety Phrases ]:
36/37
[ RIDADR ]:
UN 3439 6.1/PG III
[ WGK Germany ]:
3
[ Packaging Group ]:
III
[ HS Code ]:
2926909090
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Customs
[ HS Code ]: 2926909090
[ Summary ]:
HS:2926909090 other nitrile-function compounds VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0%
Articles
J. Med. Chem. 32 , 2344, (1989)
A novel class of low molecular weight protein tyrosine kinase inhibitors is described. These compounds constitute a systematic series of molecules with a progressive increase in affinity toward the su...
Science 242(4880) , 933-5, (1988)
A systematic series of low molecular weight protein tyrosine kinase inhibitors were synthesized; they had progressively increasing affinity over a 2500-fold range toward the substrate site of epiderma...
Nat. Med. 5(1) , 71-7, (1999)
Adeno-associated virus 2 (AAV)-based vectors have gained attention as a potentially useful alternative to the more commonly used retroviral and adenoviral vectors for human gene therapy. Although AAV ...